Thompson Siegel & Walmsley’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-208,808
Closed -$3.12M 401
2024
Q4
$3.12M Sell
208,808
-2,053,571
-91% -$33.5M 0.05% 224
2024
Q3
$43.3M Buy
2,262,379
+136,457
+6% +$2.83M 0.64% 63
2024
Q2
$44M Buy
2,125,922
+69,843
+3% +$1.39M 0.7% 56
2024
Q1
$38.7M Sell
2,056,079
-201,231
-9% -$3.45M 0.59% 63
2023
Q4
$32.5M Buy
2,257,310
+710,420
+46% +$9.66M 0.53% 66
2023
Q3
$26.9M Buy
1,546,890
+339,210
+28% +$7.07M 0.45% 73
2023
Q2
$25.1M Buy
1,207,680
+47,175
+4% +$1.03M 0.4% 75
2023
Q1
$27.3M Buy
1,160,505
+435,487
+60% +$11.7M 0.44% 71
2022
Q4
$20.3M Sell
725,018
-689,967
-49% -$17.6M 0.33% 83
2022
Q3
$33.1M Sell
1,414,985
-76,306
-5% -$2.3M 0.57% 64
2022
Q2
$50.3M Sell
1,491,291
-446,075
-23% -$15.6M 0.81% 50
2022
Q1
$67.7M Sell
1,937,366
-977,141
-34% -$33.4M 0.96% 35
2021
Q4
$88.7M Buy
2,914,507
+367,113
+14% +$12M 1.22% 19
2021
Q3
$83.5M Sell
2,547,394
-86,912
-3% -$2.78M 1.2% 24
2021
Q2
$79.7M Buy
+2,634,306
New +$86.7M 1.09% 28

Other funds holding OGN

Thompson Siegel & Walmsley's OGN Position: Q1 2025 in Review

Thompson Siegel & Walmsley sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 208,808 shares — an estimated $3.12M sold.

Thompson Siegel & Walmsley first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $88.7M in Q4 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Thompson Siegel & Walmsley reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 208,808 Organon & Co shares in Q1 2025, an estimated $3.12M.
  • Thompson Siegel & Walmsley first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
  • Thompson Siegel & Walmsley's Organon & Co position peaked at $88.7M in Q4 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2025, filed 9 May 2025.